A5048931164- Esophageal Cancer Research and Treatment
- Radiomics and Machine Learning in Medical Imaging
- Medical Imaging Techniques and Applications
- Esophageal and GI Pathology
- MRI in cancer diagnosis
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Neurological and metabolic disorders
- Gastric Cancer Management and Outcomes
- Folate and B Vitamins Research
- Advanced MRI Techniques and Applications
- Cancer Genomics and Diagnostics
- Heme Oxygenase-1 and Carbon Monoxide
OLVG
2021
The Netherlands Cancer Institute
2018-2020
Oncode Institute
2018-2019
Maastricht University Medical Centre
2019
Maastricht University
2019
Abstract Background Patients with a pathological complete response (pCR) after neoadjuvant chemoradiotherapy (nCRT) for oesophageal cancer may benefit from non-surgical management. The aim of this study was to determine the diagnostic performance visual assessment primary tumour nCRT on T2-weighted (T2W) and diffusion-weighted (DW) MRI. Methods locally advanced who underwent T2W- DW-MRI (1·5 T) before in two hospitals, between July 2013 September 2017, were included prospective study. Three...
Current delineation of the gross tumor volume (GTV) in esophageal cancer relies on computed tomography (CT) and combination with 18F-fluorodeoxyglucose (FDG) positron emission (PET). There is increasing interest integrating magnetic resonance imaging (MRI) radiation treatment, which can potentially obviate CT- or FDG-PET/CT-based delineation. The aim this study to evaluate feasibility target T2-weighted (T2W) MRI T2W including diffusion-weighted (T2W + DW-MRI) compared current-practice...
Planning SCOPE 2 mandated IMRT for both the standard and dose escalated arms, where 3DCRT had been used in 1 NeoSCOPE.75% of centres stated they former pre-trial, although at least 3 were only using upper 1/3 oesophageal cancers.79% our survey now use IMRT, including middle lower tumours.Type B planning algorithms, NeoSCOPE trial, 79.9% pre 83.3%.IGRT introduced a stomach filling protocol anatomical reproducibility.12.5% doing this which has risen to 50%.CBCT was IGRT trial.66.7% routinely...